Article
The SHOX gene: a new indication for GH treatment.
Journal of endocrinological investigation - 1 Jun 2010
Cicognani A, Pirazzoli P, Nicoletti A, Baronio F, Conti V, Bonetti S
Abstract excerpt
Short stature homeobox-containing (SHOX) gene mutations causing haploinsufficiency have been reported in idiopathic short stature, but the real prevalence of this defect in the population with growth failure is debated. Based on current data, the prevalence of SHOXdefect (SHOX-D) has been calculated to have occurred in at least 1 in 2,000 children. This occurrence rate is higher than that of classic GH deficiency...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
